SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-24-127644
Filing Date
2024-11-15
Accepted
2024-11-15 16:36:47
Documents
11
Period of Report
2024-11-15
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K crbp-20241115.htm   iXBRL 8-K 38981
  Complete submission text file 0000950170-24-127644.txt   159898

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT crbp-20241115.xsd EX-101.SCH 31270
13 EXTRACTED XBRL INSTANCE DOCUMENT crbp-20241115_htm.xml XML 4767
Mailing Address 500 RIVER RIDGE DRIVE NORWOOD MA 02062
Business Address 500 RIVER RIDGE DRIVE NORWOOD MA 02062 617-963-0103
Corbus Pharmaceuticals Holdings, Inc. (Filer) CIK: 0001595097 (see all company filings)

IRS No.: 464348039 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37348 | Film No.: 241468442
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)